Eton’s ET-700 pilot study shows fewer GI side effects than GALZIN, setting up a 2027 formulation push
Market Chameleon (Fri, 6-Nov 9:53 AM)
Record Revenue and Higher Guidance Highlight Eton Pharmaceuticals’ Standout Quarter
Market Chameleon (Fri, 14-Aug 10:30 AM)
Eton Pharmaceuticals Doubles Revenue and Raises Guidance Amid Strong Rare Disease Portfolio Performance
Market Chameleon (Fri, 14-Aug 7:27 AM)
